References
- Kristinsson SY, Koshiol J, Björkholm M, et al. Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia. J Natl Cancer Inst 2010;102: 557–567.
- Atienza J, Bockorny B, Dadla A, et al. Inflammatory and immune-related conditions associated with Waldenström macroglobulinemia: a single center experience. Leuk Lymphoma 2015;56:1179–1180.
- Treon SP, Xu L, Yang G, et al. MYD88 L265P somatic mutation in Waldenström’s macroglobulinemia. N Engl J Med 2012;367: 826–833.
- Wang JQ, Jeelall YS, Beutler B, et al. Consequences of the recurrent MYD88 (L265P) somatic mutation for B cell tolerance. J Exp Med 2014;211:413–426.
- Fischer M, Ehlers M. Toll-like receptors in autoimmunity. Ann NY Acad Sci 2008;1143:21–34.
- Celhar T, Magalhães R, Fairhurst AM. TLR7 and TLR9 in SLE: when sensing self goes wrong. Immunol Res 2012;53:58–77.
- Ciechomska M, Cant R, Finnigan J, et al. Role of toll-like receptors in systemic sclerosis. Expert Rev Mol Med 2013;15:e9.
- Cavalcante P, Cufi P, Mantegazza R, et al. Etiology of myasthenia gravis: innate immunity signature in pathological thymus. Autoimmun Rev 2013;12:863–874.
- Eleftheriadis T, Pissas G, Liakopoulos V, et al. Toll-like receptors and their role in renal pathologies. Inflamm Allergy Drug Targets 2012;11:464–477.